India Achieves Breakthrough in Blood Cancer Treatment with Indigenous CAR-T Therapy: 80% Patients Show No Relapse After 15 Months
‘VELCART-T’ Study by CMC Vellore and ICMR Marks New Era in Affordable Cancer Treatment First Time CAR-T Cells Manufactured Within Hospital Premises in India T.chaturvedi,DainikMore